Effects of Dapagliflozin and Metformin on Vascular Function in Newly Diagnosed Type 2 Diabetes-A Randomized Controlled Trial (DMVascular Study)

被引：0
|
作者：
Dalan, Rinkoo
Chee, Ying Jie
Zhang, Xiaoe
机构：
来源：
DIABETES | 2024年 / 73卷
基金：
英国医学研究理事会;
关键词：
D O I：
10.2337/db24-933-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
933-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
    Henry, R. R.
    Murray, A. V.
    Marmolejo, M. H.
    Hennicken, D.
    Ptaszynska, A.
    List, J. F.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (05) : 446 - 456
  • [22] The Effects of Exenatide and Metformin on Endothelial Function in Newly Diagnosed Type 2 Diabetes Mellitus Patients: A Case-Control Study
    Hu, Yanjin
    Liu, Jia
    Wang, Guang
    Xu, Yuan
    DIABETES THERAPY, 2018, 9 (03) : 1295 - 1305
  • [23] To Compare the Efficacy of Dapagliflozin & Metformin Vs Sitagliptin & Metformin in Newly Diagnosed Type 2 Diabetic patients
    Abdullah, Faiq
    Sattar, Abdul
    Shaukat, Kamran
    Ahmad, Sarfraz
    Nawaz, Shahid
    Maryam, Bushra
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (01): : 85 - 86
  • [24] Linagliptin Monotherapy Versus Initial Combination Therapy with Metformin in Patients with Newly Diagnosed Type 2 Diabetes (T2D): A Randomized Controlled Trial
    von Eynatten, Maximilian
    Ross, Stuart
    Caballero, Enrique
    Del Prato, Stefano
    Gallwitz, Baptist
    Lewis-D'Agostino, Diane
    Bailes, Zelie
    Thiemannt, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [25] Behavioral Economics-Based Financial and Social Incentives for Glycemic Control in Newly Diagnosed Type 2 Diabetes-A Randomized Control Trial
    Lai, Wai Yin Cheryl
    Ye, Jiaxi
    Ng, Carmen S.
    Quan, Jianchao
    DIABETES, 2024, 73
  • [26] Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study
    Mo, Dan
    Liu, Songfang
    Ma, Hong
    Tian, Haoming
    Yu, Honglin
    Zhang, Xiangxun
    Tong, Nanwei
    Liao, Jiayu
    Ren, Yan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2769 - 2776
  • [27] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
    Pavlicek, V.
    DIABETOLOGE, 2011, 7 (01): : 37 - 38
  • [28] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Clifford J Bailey
    Jorge L Gross
    Delphine Hennicken
    Nayyar Iqbal
    Traci A Mansfield
    James F List
    BMC Medicine, 11
  • [29] Randomized Controlled Trial of Ipragliflozin or Sitagliptin Combined with Metformin in Type 2 Diabetes: NISM Study
    Kitazawa, Masaru
    Katagiri, Takashi
    Suzuki, Hiromi
    Matsunaga, Satoshi
    Yamada, Mayuko H.
    Ikarashi, Tomoo
    Yamamoto, Masahiko
    Furukawa, Kazuo
    Iwanaga, Midori
    Hatta, Mariko
    Fujihara, Kazuya
    Yamada, Takaho
    Tanaka, Shiro
    Sone, Hirohito
    DIABETES, 2020, 69
  • [30] Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
    Bailey, Clifford J.
    Gross, Jorge L.
    Hennicken, Delphine
    Iqbal, Nayyar
    Mansfield, Traci A.
    List, James F.
    BMC MEDICINE, 2013, 11
12345